These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 27013138)

  • 1. MicroRNA: A new therapeutic strategy for cardiovascular diseases.
    Samanta S; Balasubramanian S; Rajasingh S; Patel U; Dhanasekaran A; Dawn B; Rajasingh J
    Trends Cardiovasc Med; 2016 Jul; 26(5):407-19. PubMed ID: 27013138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA Signature and Cardiovascular Dysfunction.
    Arunachalam G; Upadhyay R; Ding H; Triggle CR
    J Cardiovasc Pharmacol; 2015 May; 65(5):419-29. PubMed ID: 25384197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA in cardiovascular biology and disease.
    Wojciechowska A; Braniewska A; Kozar-Kamińska K
    Adv Clin Exp Med; 2017 Aug; 26(5):865-874. PubMed ID: 29068585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs as Candidate Drug Targets for Cardiovascular Diseases.
    Hang P; Guo J; Sun C; Du Z
    Curr Drug Targets; 2017; 18(4):463-472. PubMed ID: 26926467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The therapeutic and diagnostic role of exosomes in cardiovascular diseases.
    Zamani P; Fereydouni N; Butler AE; Navashenaq JG; Sahebkar A
    Trends Cardiovasc Med; 2019 Aug; 29(6):313-323. PubMed ID: 30385010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA and Cardiovascular Diseases.
    Çakmak HA; Demir M
    Balkan Med J; 2020 Feb; 37(2):60-71. PubMed ID: 32018347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs Mediate Beneficial Effects of Exercise in Heart.
    Bei Y; Tao L; Cretoiu D; Cretoiu SM; Xiao J
    Adv Exp Med Biol; 2017; 1000():261-280. PubMed ID: 29098626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. microRNAs in cardiovascular diseases: current knowledge and the road ahead.
    Condorelli G; Latronico MV; Cavarretta E
    J Am Coll Cardiol; 2014 Jun; 63(21):2177-87. PubMed ID: 24583309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular RNA interference therapy: the broadening tool and target spectrum.
    Poller W; Tank J; Skurk C; Gast M
    Circ Res; 2013 Aug; 113(5):588-602. PubMed ID: 23948584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Non-coding RNA : Innovative regulators with therapeutic perspective].
    Bührke A; Bär C; Thum T
    Herz; 2018 Mar; 43(2):115-122. PubMed ID: 29236145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implication of microRNAs in the development and potential treatment of radiation-induced heart disease.
    Kura B; Babal P; Slezak J
    Can J Physiol Pharmacol; 2017 Oct; 95(10):1236-1244. PubMed ID: 28679064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs as pharmacological targets in endothelial cell function and dysfunction.
    Chamorro-Jorganes A; Araldi E; Suárez Y
    Pharmacol Res; 2013 Sep; 75():15-27. PubMed ID: 23603154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs in the Pathobiology and Therapy of Atherosclerosis.
    Laffont B; Rayner KJ
    Can J Cardiol; 2017 Mar; 33(3):313-324. PubMed ID: 28232017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role and Molecular Mechanism of Non-Coding RNAs in Pathological Cardiac Remodeling.
    Gao J; Xu W; Wang J; Wang K; Li P
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28287427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular vesicle microRNA transfer in cardiovascular disease.
    Das S; Halushka MK
    Cardiovasc Pathol; 2015; 24(4):199-206. PubMed ID: 25958013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The emerging role of microRNAs in cardiovascular disease.
    Maegdefessel L
    J Intern Med; 2014 Dec; 276(6):633-44. PubMed ID: 25160930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of microRNAs in gastrointestinal smooth muscle fibrosis and dysfunction: novel molecular perspectives on the pathophysiology and therapeutic targeting.
    Krishna CV; Singh J; Thangavel C; Rattan S
    Am J Physiol Gastrointest Liver Physiol; 2016 Apr; 310(7):G449-59. PubMed ID: 26822916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNA therapeutics in cardiovascular disease models.
    Dangwal S; Thum T
    Annu Rev Pharmacol Toxicol; 2014; 54():185-203. PubMed ID: 24111539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical potential of adipogenesis and obesity-related microRNAs.
    Zaiou M; El Amri H; Bakillah A
    Nutr Metab Cardiovasc Dis; 2018 Feb; 28(2):91-111. PubMed ID: 29170059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review - MicroRNAs: A new paradigm towards mechanistic insight of diseases.
    Nadeem A; Ashraf MR; Javed M; Hussain T; Tariq MS; Babar ME
    Pak J Pharm Sci; 2018 Sep; 31(5):2017-2026. PubMed ID: 30150203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.